Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma.
J Exp Clin Cancer Res. 2024 Mar 12;43(1):77. doi: 10.1186/s13046-024-02995-z.
J Exp Clin Cancer Res. 2024.
PMID: 38475864
Free PMC article.
Crenolanib is a type I tyrosine kinase inhibitor that inhibits mutant KIT D816 isoforms prevalent in systemic mastocytosis and core binding factor leukemia.
Kampa-Schittenhelm KM, Frey J, Haeusser LA, Illing B, Pavlovsky AA, Blumenstock G, Schittenhelm MM.
Kampa-Schittenhelm KM, et al. Among authors: haeusser la.
Oncotarget. 2017 Aug 7;8(47):82897-82909. doi: 10.18632/oncotarget.19970. eCollection 2017 Oct 10.
Oncotarget. 2017.
PMID: 29137311
Free PMC article.
Item in Clipboard
Cite
Cite